Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Top Cited Papers
Open Access
- 11 April 2020
- journal article
- editorial
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 41 (6), 363-382
- https://doi.org/10.1016/j.tips.2020.03.006
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the futurePharmacology & Therapeutics, 2016
- SARS and MERS: recent insights into emerging coronavirusesNature Reviews Microbiology, 2016
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysNature, 2016
- Evaluation of Convalescent Plasma for Ebola Virus Disease in GuineaThe New England Journal of Medicine, 2016
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trialThe Lancet Respiratory Medicine, 2015
- Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken EggsJournal of Virology, 2010
- The economic impact of SARS: How does the reality match the predictions?Health Policy, 2008
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Clinical trial registration: a statement from the International Committee of Medical Journal EditorsThe Lancet, 2004
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004